186 related articles for article (PubMed ID: 1562738)
21. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
Lee JT; Innes DJ; Williams ME
J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
[TBL] [Abstract][Full Text] [Related]
22. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
[TBL] [Abstract][Full Text] [Related]
23. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
Koduru PR; Chen W; Garcia R; Fuda F
Cancer Genet; 2015 Jun; 208(6):303-9. PubMed ID: 25953460
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon.
Zani VJ; Asou N; Jadayel D; Heward JM; Shipley J; Nacheva E; Takasuki K; Catovsky D; Dyer MJ
Blood; 1996 Apr; 87(8):3124-34. PubMed ID: 8605326
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
[TBL] [Abstract][Full Text] [Related]
26. MYC/BCL2 double- and MYC/BCL2/BCL6 triple-hit follicular lymphomas associated with t(8;14;18)(q24;q32;q21).
Takeoka K; Maekawa F; Nakagawa M; Kishimori C; Fukutsuka K; Hayashida M; Sumiyoshi S; Ohno H
J Clin Exp Hematop; 2022; 62(4):258-267. PubMed ID: 36575003
[TBL] [Abstract][Full Text] [Related]
27. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients.
Godon A; Moreau A; Talmant P; Baranger-Papot L; Geneviève F; Milpied N; Zandecki M; Avet-Loiseau H
Leukemia; 2003 Jan; 17(1):255-9. PubMed ID: 12529690
[TBL] [Abstract][Full Text] [Related]
28. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.
Murga Penas EM; Callet-Bauchu E; Ye H; Gazzo S; Berger F; Schilling G; Albert-Konetzny N; Vettorazzi E; Salles G; Wlodarska I; Du MQ; Bokemeyer C; Dierlamm J
Blood; 2010 Mar; 115(11):2214-9. PubMed ID: 19965626
[TBL] [Abstract][Full Text] [Related]
29. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
[TBL] [Abstract][Full Text] [Related]
30. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive.
Bosga-Bouwer AG; van Imhoff GW; Boonstra R; van der Veen A; Haralambieva E; van den Berg A; de Jong B; Krause V; Palmer MC; Coupland R; Kluin PM; van den Berg E; Poppema S
Blood; 2003 Feb; 101(3):1149-54. PubMed ID: 12529293
[TBL] [Abstract][Full Text] [Related]
31. Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.
Ouansafi I; He B; Fraser C; Nie K; Mathew S; Bhanji R; Hoda R; Arabadjief M; Knowles D; Cerutti A; Orazi A; Tam W
Am J Clin Pathol; 2010 Dec; 134(6):972-81. PubMed ID: 21088162
[TBL] [Abstract][Full Text] [Related]
32. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
33. Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.
Vergier B; Belaud-Rotureau MA; Benassy MN; Beylot-Barry M; Dubus P; Delaunay M; Garroste JC; Taine L; Merlio JP
Am J Surg Pathol; 2004 Jun; 28(6):748-55. PubMed ID: 15166666
[TBL] [Abstract][Full Text] [Related]
34. The novel double-hit, t(8;22)(q24;q11)/MYC-IGL and t(14;15)(q32;q24)/IGH-BCL2A1, in diffuse large B-cell lymphoma.
Akasaka T; Kishimori C; Fukutsuka K; Nakagawa M; Takeoka K; Hayashida M; Honjo G; Ohno H
Cancer Genet; 2017 Aug; 214-215():26-31. PubMed ID: 28595732
[TBL] [Abstract][Full Text] [Related]
35. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene.
Akasaka T; Akasaka H; Ueda C; Yonetani N; Maesako Y; Shimizu A; Yamabe H; Fukuhara S; Uchiyama T; Ohno H
J Clin Oncol; 2000 Feb; 18(3):510-18. PubMed ID: 10653866
[TBL] [Abstract][Full Text] [Related]
36. MYC rearrangements in histologically progressed follicular lymphomas.
Yano T; Jaffe ES; Longo DL; Raffeld M
Blood; 1992 Aug; 80(3):758-67. PubMed ID: 1638027
[TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas.
Streubel B; Scheucher B; Valencak J; Huber D; Petzelbauer P; Trautinger F; Weihsengruber F; Mannhalter C; Cerroni L; Chott A
Am J Surg Pathol; 2006 Apr; 30(4):529-36. PubMed ID: 16625101
[TBL] [Abstract][Full Text] [Related]
38. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma.
Voso MT; Hohaus S; Moos M; Haas R
Blood; 1997 May; 89(10):3763-8. PubMed ID: 9160682
[TBL] [Abstract][Full Text] [Related]
39. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells.
Fenton JA; Vaandrager JW; Aarts WM; Bende RJ; Heering K; van Dijk M; Morgan G; van Noesel CJ; Schuuring E; Kluin PM
Blood; 2002 Jan; 99(2):716-8. PubMed ID: 11781262
[TBL] [Abstract][Full Text] [Related]
40. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
